✦ LIBER ✦

Autocrine and paracrine growth regulation of breast cancer: Clinical implications

✍ Scribed by C. Kent Osborne; Carlos L. Arteaga

Publisher: Springer US
Year: 1990
Tongue: English
Weight: 775 KB
Volume: 15
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01811884

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myoepithelial Cells: Autocrine and Parac

Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression

✍ Sanford H. Barsky; Nina J. Karlin 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 760 KB

Myoepithelial Cells: Autocrine and Parac

Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression

✍ Sanford H. Barsky; Nina J. Karlin 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 760 KB

The role of cytokines and hematopoietic

The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis

✍ F. H. M. Cluitmans; B. H. J. Esendam; W. F. J. Veenhof; J. E. Landegent; R. Will 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 327 KB

Expression of growth factors, growth inh

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

✍ de Jong, Johannes S.; van Diest, Paul J.; van der Valk, Paul; Baak, Jan P. A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

Regulation of interleukin-6 secretion fr

Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications

✍ Junichi Kurebayashi 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 577 KB

IL-6 promotes malignant growth of skin S

IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines

✍ Wiltrud Lederle; Sofia Depner; Sabine Schnur; Eva Obermueller; Nicola Catone; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 878 KB

## Abstract Cytokines play a crucial role in tumor initiation and progression. Here, we demonstrate that interleukin (IL)‐6 is a key factor by driving tumor progression from benign to malignant, invasive tumors in the HaCaT‐model of human skin carcinoma. IL‐6 activates STAT3 and directly stimulates